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Objectives The authors sought to investigate the impact of distal embolization (DE) on myocardial
damage and microvascular reperfusion, according to time-to-treatment, using contrast-enhanced
cardiac magnetic resonance (CE-CMR).
Background DE, occurring during primary percutaneous coronary intervention (p-PCI), appears to
increase myocardial necrosis and to worsen microvascular perfusion, as shown by surrogate markers.
However, data regarding the behavior of DE on jeopardized myocardium, and in particular on ne-
crosis extent and distribution, are still lacking.
Methods In 288 patients who underwent p-PCI within 6 h from symptom onset, the authors pro-
spectively assessed the impact of DE on infarct size and microvascular damage, using CE-CMR. The
impact of DE was assessed according to time-to-treatment: for group 1, 3 h; for group 2, 3 and
6 h.
esults DE occurred in 41 (14.3%) patients. Baseline clinical characteristics were not different be-
ween the 2 groups. At CE-CMR, patients with DE showed larger infarct size (p  0.038) and more
often transmural necrosis compared with patients without DE (p  0.008) when time-to-treatment
was 3 h, but no impact was proven after this time (p  NS). Patients with DE showed more often
microvascular obstruction, as evaluated at ﬁrst-pass enhancement, than patients without DE (100%
vs. 66.5%, p  0.001) up to 6 h from symptom onset.
Conclusions These ﬁndings suggest that the detrimental impact of DE occurring during p-PCI on
myocardial damage is largely inﬂuenced by ischemic time, increasing the extent of necrosis in pa-
tients presenting within the ﬁrst hours after symptom onset, and having limited or no impact after
this time window. (J Am Coll Cardiol Intv 2012;5:1170–7) © 2012 by the American College of
Cardiology Foundation
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1171Distal embolization (DE) of macroscopic debris in the
coronary circulation, as detected by coronary angiography,
has been reported in about 14% of patients undergoing
primary-percutaneous coronary intervention (p-PCI) for
ST-segment elevation myocardial infarction (STEMI), ac-
counting in most of them for impaired microvascular
perfusion and larger myocardial damage (1). However,
several randomized trials assessing the use of mechanical
adjunctive devices aiming to reduce DE have reported
conflicting evidences in terms of myocardial reperfusion and
myocardial salvage (2). Indeed, even when the p-PCI is
performed with respect for coronary microcirculation by use
of protection devices on top of triple antiplatelet therapy,
angiographically detectable DE may still occur in up to 6%
of patients with a poorer outcome (3). These results have
raised concerns, not only on the effectiveness of mechanical
devices in preventing DE during p-PCI, but also, and more
importantly, on the impact of DE by itself on myocardial
and microvascular damage (4). The restoration of an ade-
quate coronary flow represents only the first step toward
successful myocardial reperfusion and myocardial salvage in
STEMI. In fact, the effectiveness of reperfusion therapy
depends on several factors, including the duration of ische-
mia (5), the presence of residual coronary flow by either
antegrade flow (6) or collateral circulation (7), and the extent of
risk area (8). Thus, it could be argued that the detrimental
impact of DE may be strongly influenced by these factors and
mainly by duration of ischemia and myocardium viability at
time of flow restoration (8–10). We recently reported on the
time-dependent impact of angiographically detectable DE
during p-PCI on myocardial reperfusion and myocardial ne-
crosis, as evaluated by myocardial blush and troponin I release,
respectively (11). However, data regarding the behavior of DE
on jeopardized myocardium, and in particular on necrosis
extent and distribution, are still lacking. In the last decade,
contrast-enhanced cardiac magnetic resonance (CE-CMR)
has shown great potential in detecting myocardial scar after
myocardial infarction, as well as in assessing the extent and
distribution of necrosis (12,13). Indeed, this tool has been
useful to study the presence of microvascular damage in the
context of necrotic scar (12–15). The aim of the present study
was to assess the impact of DE during p-PCI, on either
myocardial or microvascular damage according to ischemic
time, by CE-CMR.
Methods
Study population. We analyzed data from 288 subjects
ncluded in an ongoing prospective registry. All patients
ndergoing p-PCI, within 6 h from symptom onset, and
E-CMR at our institution were enrolled. Inclusion criteria
ere continuous chest pain for at least 20 min and within
h of symptom onset and the following: 1) ST-segmentlevation1 mm (0.1 mV) in 2 or more contiguous leads on Che 12-lead electrocardiogram; 2) persistent ST-segment
epression in precordial leads V1 to V4, with or without
ST-segment elevation in inferior or lateral leads; or 3) new-
onset left bundle branch block. Exclusion criteria were the
use of adjunctive mechanical devices (both thrombectomy
catheters and distal protection devices), previous myocardial
infarction, electric or hemodynamic instability during hos-
pitalization, and contraindication to CE-CMR. p-PCI was
performed with a standard technique by femoral or radial
approach according to physician choice. The infarct-related
artery (IRA) was the only target of the procedure, and
coronary bare-metal stents were used in all cases. The
procedure was considered successful if Thrombolysis In
Myocardial Infarction (TIMI) flow grade 3 in the target
vessel and a residual stenosis 20% at target site were
obtained. Before the procedure, all patients received aspirin
250 to 500 mg intravenously,
thereafter 100 to 325 mg/day;
heparin (70 U/kg) was given to
maintain the activated clotting
time 250 s. Clopidogrel was
given as soon as possible after
hospital admission at a bolus dose
of 300 to 600 mg and then at a
dose of 75 mg once a day. Abcix-
imab was given according to the
judgment of the operator in the
catheterization laboratory. All pa-
tients gave written informed con-
sent for the procedure. The study
complies with the Declaration of
Helsinki, and the ethics review
board of our institution approved
the study.
Angiographic analysis. Coro-
ary angiograms were acquired
igitally (Integris 5000, Philips
edical Systems, Best, the
etherlands). The angiographic analysis was performed
ffline by 2 experienced operators blinded to clinical data
11). TIMI flow grade and myocardial blush grade were
ssessed as previously described (16,17). Intracoronary
hrombus at baseline was angiographically identified and
cored in 5° according to TIMI thrombus score (18). To
etter define the thrombus burden in case of IRA occlusion,
he angiographic pattern of coronary occlusion, when pres-
nt, was defined on baseline angiogram as follows: 1) cutoff
attern, when there was an abrupt occlusion of the epicar-
ial vessel; 2) tapered occlusion, when there was a vessel
apering just before the occlusion; and 3) persistent dye
attern, when there was dye staining just proximally and/or
istally to the occlusion (11). Quantitative coronary analysis
as performed at baseline and after procedure, using the
Abbreviations
and Acronyms
CE-CMR  contrast-
enhanced cardiac magnetic
resonance
DE  distal embolization
IRA  infarct-related artery
ISI  infarct size index
LGE  late gadolinium
enhancement
p-PCI  primary
percutaneous coronary
intervention
PMD  persistent
microvascular damage
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis in
Myocardial Infarctionoronary Quantification Package (Philips Medical Sys-
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1172tems) as previously described (11). DE was defined as a
distal filling defect with an abrupt occlusion in distal IRA or
in 1 or more peripheral coronary branches of the IRA, distal
to the PCI site; in particular, we did not consider as DE the
occurrence of TIMI flow impairment, at any stage of the
procedure, without evidence of a distal filling defect (11).
CE-CMR image protocol. The patients were examined by
.5-T scanner (Harmony, Siemens, Erlangen, Germany)
mplemented with cardiological software (MRease SYNGO
002B, Siemens). The CE-CMR examination was acquired
to 8 days after revascularization. Electrocardiogram-gated
reathhold cine images were acquired using a segmented
teady-state free-precession pulse sequence (true fast imag-
ng with steady state precession [TrueFISP]) in multiple
hort-axis views every 8 mm by encompassing the left
entricle from base to apex; vertical and horizontal long-axis
iews were also acquired. Typical in-plane resolution is
.6  1.9 mm 2, with slice thickness  8 mm; TE  1.75
s, TR  3.5 ms, flip angle (FA)  60°, matrix  256 
56, slice thickness  8 mm, gap  2 mm. Rest first-pass
yocardial perfusion was performed during administration
f a gadolinium-based contrast agent (Multihance, 0.2
mol/kg, Bracco, Milan, Italy), using a single-shot satura-
ion recovery gradient echo pulse sequence. Three short-axis
lices were obtained per heartbeat, every 10 mm, covering
he infarct area as seen during cine imaging (90° pre-pulse,
R/TE/FA 2.5 ms/1.3 ms/20°, slice thickness  10 mm,
atrix  128  256, number of excitations  1).
Late gadolinium enhancement (LGE) images were acquired
0 to 15 min after contrast administration (19), using a
-dimensional segmented inversion recovery gradient echo pulse
equence, with slice position identical to the cine images, including
ong-axis views. Sequence parameters were the following: TR 
50 ms, TE  1.31 ms, (FA)  15°, slice thickness  8 mm,
ap  2 mm. The inversion time was set to null the signal of
iable myocardium (typical range: 250 to 300 ms).
CE-CMR image analysis. Cine, first-pass perfusion, and
LGE images were acquired during the same imaging session
and matched using slice position; finally, the images were
analyzed using a 17-segment model (20,21). On all short-
axis cine slices, the endocardial and epicardial borders were
outlined manually on end-diastolic and end-systolic images.
First-pass perfusion was evaluated qualitatively according to
the 17-segment model (22). Persistent microvascular dam-
age (PMD) was finally evaluated on LGE images as the
presence of a hypoenhancement region, with decreased
signal intensity (15,23). Extent of necrosis was judged as
transmural if LGE extended to 75% of thickness of the
myocardial wall in 2 or more segments (20). For analysis of
transmural extent of infarction, the 2 most basal and most
distal slices were excluded, because segmental evaluation at
these levels is not considered to be reliable due to the left
ventricular outflow tract and partial volume effect, respec-
tively. The infarct size index (ISI) was quantified by (manually drawing short-axis slices and is expressed as
percentage of left ventricular mass. The presence of PMD
was included in the infarcted area. All CE-CMR measure-
ments were performed independently by 2 observers who
were blinded to clinical and procedural data.
Measures of outcome. Major adverse events occurring dur-
ing the hospitalization, including death, nonfatal reinfarc-
tion, and stroke, were collected. Diagnosis of nonfatal
reinfarction was based on typical chest pain and/or new
ST-segment changes with troponin I level re-elevation (11).
The troponin I levels were reported as micrograms/liter, and
were assessed every 6 h in the first 48 h after admission,
and then twice daily up to discharge (11). Peak value
release from 8 serial measurements up to 48 h after
admission was reported (11). Stroke was defined by
development of new cognitive or neurological deficits
confirmed by computed tomography or magnetic reso-
nance imaging. Two-dimensional echocardiography was
performed in all patients pre-discharge.
Statistical analysis. Categorical data are expressed as numbers
nd percentages, and were compared using the chi-square or
isher exact test, as appropriate. Continuous variables are
xpressed as mean  SD for normally distributed variables,
nd as median (25th to 75th percentiles) for not normally
istributed variables, and compared using the analysis of
ariance and Mann-Whitney U tests, respectively. The poten-
ial predictors of transmural necrosis were evaluated 1 variable
t a time in a univariable logistic regression model. The
otential predictors were age, diabetes, ischemic time, multi-
essel disease, patent IRA at baseline, presence of collaterals,
nal TIMI flow grade 3, abciximab use, and occurrence of DE.
ariables that showed significant association with transmural
ecrosis on univariable analysis (p  0.10) were entered in a
ultivariable logistic regression model, and a p  0.05 was
onsidered statistically significant. The results of the univari-
ble and multivariable analyses are reported as p values, odds
atios, and 95% confidence intervals. To assess the impact of
E on myocardial and microvascular damage according to
ime-to-treatment, defined as time from symptom onset to
rst balloon inflation, patients were divided into 2 groups as
ollows: group 1, including 146 patients treated 3 h from
ymptom onset; and group 2, including 142 patients with
ymptom onset-to-balloon time 3 and 6 h. Because base-
ine clinical and angiographic characteristics did not differ
etween groups, a secondary analysis to compare CE-CMR
easurements and DE occurrence was performed in these
roups, using the chi-square test for categorical variables and
nalysis of variance or Mann-Whitney U test for continuous
ariables, respectively. A p value 0.05 with the 2-tailed test
as considered statistically significant. Intraobserver and inter-
bserver reproducibility of CE-CMR measurements were
ssessed using the Pearson correlation analysis. Statistical
nalysis was carried out by SPSS software package, version 16.0
SPSS, Chicago, Illinois).
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1173Results
Out of 288 patients enrolled, 41 (14.3%) showed DE and
247 (85.7%) did not. Baseline clinical findings were similar
between patients with DE and patients without DE (Table 1).
Particularly, pain-to-balloon time did not differ between pa-
tients with and those without DE (Table 1). No sex-based
differences were detected (Table 1).
After dividing patients into 2 groups according to ische-
mic time, DE appeared not to be time dependent, occurring
in 20 of 146 (13.7%) patients treated before 3 h and in 21
of 142 (14.8%) patients treated between 3 and 6 h (p 
0.78). Angiographic analysis at baseline revealed that pa-
tients in the DE group had a higher rate of occluded IRA
(Table 2). Indeed, in the presence of an occluded IRA,
patients in DE group showed in almost two-thirds of cases
a “cutoff” pattern, whereas the tapered pattern was more
frequent in patients without DE (Table 2). Patients in the
DE group also had larger thrombus burden as assessed by
TIMI thrombus score, longer lesion, and larger reference
vessel diameter compared with patients without DE
(Table 2). Abciximab was given more often in patients with
DE (Table 2). At the end of procedure, patients experienc-
ing DE had worse TIMI flow grade and myocardial blush,
than did patients without DE (Table 2). Procedural success
occurred in 30 of 41 (73.2%) patients with DE and in 234
of 247 (94.7%) patients without DE (p  0.0001).
Relationship between DE, ischemic time, and myocardial
damage on CE-CMR. At CE-MR, ISI was significantly
larger in patients with DE than in patients without, partic-
ularly in those treated within 3 h (Fig. 1A). However, after
this time, as the ISI of patients without DE increased, it did
Table 1. Baseline Characteristics
DE (n  41)
(14.3%)
No DE (n  247)
(85.7%) p Value
Age, yrs 61 (55–70) 60 (50–67) 0.49
Male 36 (87.8%) 204 (82.6%) 0.41
Hypertension 22 (53.7%) 123 (49.8%) 0.65
Dyslipidemia 22 (54.5%) 111 (44.7%) 0.29
Diabetes mellitus 8 (19.5%) 40 (16.2%) 0.60
Smoke 30 (73.2%) 154 (62.3%) 0.18
Familiar history 18 (43.9%) 122 (49.5%) 0.51
Previous angina 11 (26.8%) 69 (27.9%) 0.05
Pain-to-balloon time, min 185 (120–305) 180 (131–285) 0.13
Troponin I peak, g/l 112 (58–187) 68.5 (26.3–143.3) 0.01
Pre-discharge 2D echo
EDVI, ml/m2 66.1 11.9 61.4 13.6 0.14
ESVI, ml/m2 33 11.5 31.4 11 0.66
LVEF, % 51.5 6.8 49.9 8.7 0.45
Values are median (25th to 75th percentile), n (%), or mean SD.
2D  2-dimensional; CABG  coronary artery bypass graft; DEdistal embolization; EDVI 
end-diastolic volume index; ESVI  end-systolic volume index; LVEF  left ventricular ejectionfraction; PCI percutaneous coronary intervention.not differ between patients with and without DE (Fig. 1A).
Moreover, myocardial necrosis was more often transmural
in patients showing DE than in patients who did not (Fig.
1B). Particularly, the occurrence of DE significantly im-
pacted the transmural extent of necrosis in patients treated
within the first 3 h from symptom onset: transmural
necrosis was detected in 84.6% of patients with DE and in
51.6% of patients without DE, respectively (p  0.025)
(Fig. 1B). After this time, the transmural extent of myocar-
dial necrosis was no longer significantly affected by DE:
transmural necrosis was detected in 84.6% and in 64.3% of
patients, respectively (p  0.15) (Fig. 1B). Patients experi-
encing DE showed more often PMD, as compared with
patients without DE (Fig. 1C), when time-to-treatment
was within 3 h; however, the impact of DE on severe
microvascular damage was no longer appreciable when
time-to-treatment was longer. Indeed, patients with DE
showed more often microvascular obstruction, as evaluated
in first-pass images, than patients without DE, showing
statistically significant differences at both time points (Fig. 1D,
Table 3). In particular, patients experiencing DE developed
Table 2. Angiographic Characteristics
DE (n  41)
(14.3%)
No DE (n  247)
(85.7%) p Value
Infarct-related artery 0.82
Left anterior descending 23 (56.1%) 133 (53.8%)
Circumﬂex artery 4 (9.8%) 23 (9.4%)
Right coronary artery 14 (34.1%) 91 (36.8%)
Multivessel disease 17 (42%) 128 (52%) 0.29
Collateral ﬂow (Rentrop 2/3) 9 (22%) 57 (23%) 0.83
Occlusion pattern 0.001
Patent IRA (TIMI ﬂow
grade 2/3)
7 (18.2%) 66 (26.6%)
Cutoff 26 (63.6%) 73 (29.7%)
Tapered 4 (9.1%) 81 (33.2%)
Persistent dye 4 (9.1%) 27 (0.11%)
TIMI thrombus score 3 37 (90.9%) 183 (74.2%) 0.035
QCA before PCI
Lesion length 19.3 (15.7–23.3) 16.7 (13.5–21.7) 0.023
RVD, mm 3.17 (2.75–3.56) 2.78 (2.4–3.14) 0.0001
DS, % 100 (99.9–100) 100 (94–100) 0.013
MLD, mm 0 (0–0.01) 0 (0–0.62) 0.022
QCA post PCI
RVD 3.24 (2.71–3.5) 3 (2.58–3.35) 0.038
DS, % 11 (4.5–15.5) 10 (5–15) 0.52
MLD, mm 2.78 (2.46–3.14) 2.73 (2.41–3.05) 0.382
TIMI ﬂow grade 3 after PCI 30 (72.7%) 234 (94.7%) 0.0001
MBG 2/3 after PCI 11 (27.3%) 172 (69.6%) 0.0001
Abciximab 28 (70%) 87 (35.3%) 0.0001
Values are n (%) or median (25th to 75th percentile).
DS diameter stenosis; IRA infarct-related artery; MBGmyocardial blush grade; MLD
minimal lumen diameter; QCA  quantitative coronary angiography; RVD  reference vessel
diameter; TIMI Thrombolysis In Myocardial Infarction; other abbreviations as in Table 1.microvascular obstruction in all cases, whereas patients without
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1174DE showed this in about two-thirds of cases. Examples of
CE-CMR findings in terms of myocardial and microvascular
damage in patients with and without DE according to time-
to-treatment have been represented in Figures 2 and 3.
Correlation indexes (r) of transmural necrosis/microvascular
damage and ISI measurements were 0.94 and 0.94 for inter-
observer variability and 0.95 and 0.95 for intraobserver vari-
ability, respectively. At univariable analysis, the patency of IRA
at baseline, the occurrence of DE, and time-to-treatment
correlated with the presence of transmural necrosis at CE-
CMR. Multivariable analysis identified time-to-treatment and
occurrence of distal embolization as independent predictors of
transmural necrosis (Table 3). Troponin I peak values were
significantly higher in the DE group than in patients without
DE (Table 1). In-hospital events were not different between
50 
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Discussion
Detrimental impact of distal embolization on myocardial and
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1175impairment of microcirculation has a multifactorial etiology
(25). Moreover, the effectiveness of myocardial reperfusion and
myocardial salvage seems largely time dependent, with myo-
cardial necrosis increasing as time-to-treatment increases (8–
0). Recently, we were able to demonstrate a time-related
mpact of DE occurring during p-PCI on myocardial reperfu-
ion and myocardial necrosis, as evaluated by myocardial blush
nd troponin I release, respectively (11). In particular, DE,
ssessed as angiographic distal filling defects, seems to impair
Table 3. Univariable and Multivariable Analysis: Predictors of Transmural
Necrosis at CE-CMR
Univariable Analysis Multivariable Analysis
OR 95% CI p Value OR 95% CI p Value
Collateral circulation 1.51 0.78–2.92 0.22 — — —
Age, 1/yr 0.99 0.97–1.02 0.81 — — —
Patent IRA 0.62 0.36–1.07 0.08 0.73 0.41–1.29 0.28
Distal embolization 2.57 1.06–6.19 0.03 2.51 1.02–6.17 0.04
Final TIMI ﬂow grade 3 0.67 0.25–1.82 0.44 — — —
Pain-to-balloon time
(30 min)
1.06 1.01–1.11 0.01 1.06 1.01–1.12 0.01
Diabetes mellitus 1.14 0.52–2.50 0.74 — — —
Abciximab 0.89 0.65–1.26 0.26 — — —
Multivessel disease 0.78 0.46–1.32 0.36 — — —
CE-CMR contrast-enhanced cardiac magnetic resonance; CI confidence interval; OR odds
ratio; other abbreviations as in Table 2.
A 
B 
Base 
Figure 2. CE-CMR Findings in the “Early Comers” (<3 h) According to DE
When distal embolization occurred in patients treated early after symptoms onset (wit
Patient with 120 min of pain-to-balloon delay, ﬁnal Thrombolysis In Myocardial Infarct
CE-CMR shows transmural necrosis with evidence of severe microvascular damage. (B
shows not-transmural necrosis without microvascular damage. LAD  left anterior descendinmyocardial reperfusion and to increase myocardial damage in
patients treated early after symptoms onset, having limited
relevance or even no impact on reperfusion and infarct size in
the late comers, among whom many patients may have already
developed transmural infarction at the time of IRA reopening
(11). Accordingly, the present study was able to demonstrate,
for the first time by means of CE-CMR, that DE has a
detrimental effect on both myocardial and microvascular dam-
age, increasing the extent of necrosis and impairing microvas-
cular perfusion. Moreover, our results confirm and extend the
notion that the impact of DE on myocardial damage appears
time dependent: DE significantly impairs myocardial damage
within the first hours after symptom onset, but it seems not to
have a major impact as ischemic time increases. Indeed, it is
important to remark that patients experiencing DE in our
study not only had larger areas of necrosis, as assessed by ISI,
but also had more severe damage, as shown by the occurrence
of transmural necrosis and persistent microvascular damage
(13). Interestingly, our study also demonstrates that patients
with DE showed in almost all cases microvascular obstruction,
as evaluated by first-pass images. However, DE seems to exert
a major impact on microvascular perfusion even behind the
first 3 h after symptom onset.
Time-dependent effect of adjunctive mechanical and pharmaco-
logical therapy in STEMI. It seems very important to speculate
on the discrepancy observed with regard to the different
time-related impact of DE on reperfusion and myocardial
 Apex 
), it was signiﬁcantly related to transmural necrosis and microvascular damage. (A)
I) ﬂow grade 3 complicated by distal embolization in the LAD, the corresponding
o-balloon time 135 min, ﬁnal TIMI ﬂow grade 3 without distal embolization, CE-CMRMid
hin 3 h
ion (TIM
) Pain-tg coronary artery; other abbreviations as in Figure 1.
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1176damage, respectively. These observations are consistent with
previous experimental and clinical data, showing that both
reperfusion and infarct size are time dependent, and that
microvascular damage lagged behind myocardial necrosis
(8,9). Indeed, these data compare well with those reported
in our previous study, showing that the impact of DE on
myocardial reperfusion and myocardial necrosis, as evalu-
ated by myocardial blush and troponin I release, respec-
tively, are time dependent but with a different time window
(11). In this regard, it is also interesting to note that our data
appear in agreement with previous observations on the
time-dependent effect of adenosine administration during
p-PCI, which was able to reduce the extent of myocardial
necrosis and clinical adverse events when given in the first
3 h after symptoms onset, but having no effect beyond this
time (26). These observations provide the proof of concept
in agreement with the evidence that every pharmacological
or mechanical therapy, aimed to reduce the extent of
myocardial damage in the setting of myocardial reperfusion,
may have no major effect in the late comers due to the
already transmural extent of necrosis at time of coronary
reopening in these patients. Indeed, the results of our study
also offer some opportunity to speculate on the conflicting
results of randomized clinical trials evaluating the role of
thrombus aspiration devices during p-PCI (2). In fact, many of
these trials showed a significant impact of adjunctive devices in
Base M
A 
B 
Figure 3. CE-CMR Findings in the “Late Comers” (>3 h) According to DE
(A) Pain-to-balloon time was 240 min, ﬁnal TIMI ﬂow grade 3, with distal emb
vascular damage. (B) Pain-to-balloon time was 300 min, ﬁnal TIMI ﬂow grade
with severe microvascular damage. Abbreviations as in Figures 1 and 2.improving myocardial reperfusion in STEMI, as assessed by Dsurrogate markers (2). However, in most of these studies, the
benefit in terms of myocardial reperfusion did not result in a
significant improvement in myocardial salvage nor in clinical
outcome (2). Nevertheless, because most of these trials in-
cluded patients treated in a broad time window (2), even
beyond the first hours after symptom onset (mostly up to 6 or
even 12 h), this apparent discrepancy could be partially ex-
plained in some of them by the time-dependent detrimental
effects of DE on myocardial damage. In fact, enrolling patients
beyond the first hours may nullify the capability of adjunctive
devices in improving myocardial reperfusion, because in late
comers, this does not translate into significant myocardial salvage.
Study limitations. Some limitations of our study should be
aken into account, in order to place our findings in the proper
erspective. First of all, our study was designed to investigate
he impact of DE occurring during p-PCI on myocardial
eperfusion and necrosis by CE-CMR; thus, excluding pa-
ients presenting contraindication to CE-CMR, as well as
atients with previous myocardial infarction, our experience
ay not reflect the real-world population of STEMI. More-
ver, at the time the study was performed, abciximab was
dministered to a relatively small number of our patients,
robably making the potential beneficial effects of this drug on
E insufficiently felt. By contrast, it is important to emphasize
hat abciximab, as administered in downstream fashion at the
perator’s discretion, was given more often in patients with
 Apex 
on; the corresponding CE-CMR shows transmural necrosis with severe micro-
out angiographic distal embolization; CE-CMR shows transmural necrosisid
olizati
3, withE. Therefore, the occurrence of DE per se may have drawn
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1177abciximab administration in some cases, rendering it impossi-
ble to draw conclusions about the effect of abciximab on the
distal embolization phenomenon. Finally, because our study
was designed to investigate the predictors and the impact of
DE occurring during p-PCI, as evaluated by coronary angiogra-
phy, we detected only the macroembolization phenomenon,
without drawing any conclusion concerning the impact of the
microembolization phenomenon.
Conclusions
Our findings suggest that the detrimental impact of DE
occurring during p-PCI on myocardial damage is largely
influenced by ischemic time, increasing the extent of necrosis
mainly in patients presenting within the first hours after
symptom onset, having limited or no impact after this time
window. These observations may partially explain the disap-
pointing results coming from randomized clinical trials evalu-
ating the effects of thrombus aspiration devices on myocardial
reperfusion and necrosis, which enrolled patients in a broad
time window. Besides, it should be emphasized that in early
comers, particularly in the presence of significant thrombus
burden, thrombus aspiration should be strongly considered in
p-PCI, to optimize myocardial reperfusion and to maximize
myocardial salvage. However, as suggested by the present study,
the definite role of thrombus aspiration during p-PCI should be
evaluated in further randomized trials enrolling patients in the
proper time interval and by using CE-CMR to assess the real
impact of thrombus aspiration on myocardial salvage.
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